
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
II. Department of Medicine, Semmelweis University, Budapest 1088, Hungary
Purpose: Recently several reverse transcription-PCR techniques have been proven to be useful for the detection of circulating micrometastases. However, this way intact cell clusters that were found in animal experiments of prognostic value could not be detected. In this study, evaluation and modification of a commercial, cytokeratin-based, immunomagnetic cell separation method was performed for the detection of intact cell clusters in colorectal carcinoma patients.
Experimental Design: Thirty-two colon cancer patients (6 were in Dukes stage B, 13 in stage C, and 13 in stage D) and 20 healthy donor samples were evaluated. Immunomagnetic cell separation was performed from the buffy coat of peripheral blood samples (20 ml) using the Carcinoma Cell Enrichment Kit (Miltenyi Biotec, Bergisch Gladbach, Germany), avoiding any filtering steps. The enriched cell fraction was cytocentrifuged and immunocytochemically labeled using a pancytokeratin antibody (MNF116; Dako).
Results: Of 20 healthy samples, 2 contained one cytokeratin-positive cell. Of 32 single samples from malignant cases, 24 showed cytokeratin-positive cells. Tumor cell clusters, mixed-cell doublets (one cytokeratin-positive and -negative cell), and mixed-cell clusters were detected in 22 of 24 patients. In six cases, cytokeratin-positive dendritic-like cells were detected. Follow-up data indicate that chemotherapy cannot destroy all of the circulating tumor cell clusters.
Conclusions: Using the methods presented, we could detect circulating colon cancer cells and cell clusters in colon carcinoma patients. Similar cellular structures were described previously only in rats. Present data prove that such structures are present in human colorectal cancer, too.
This article has been cited by other articles:
![]() |
W. He, H. Wang, L. C. Hartmann, J.-X. Cheng, and P. S. Low In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry PNAS, July 10, 2007; 104(28): 11760 - 11765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Wang, S.-R. Lin, D.-C. Wu, C.-Y. Lu, F.-J. Yu, J.-S. Hsieh, T.-L. Cheng, L.-B. Koay, and Y.-H. Uen Multiple Molecular Markers as Predictors of Colorectal Cancer in Patients with Normal Perioperative Serum Carcinoembryonic Antigen Levels Clin. Cancer Res., April 15, 2007; 13(8): 2406 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Garcia-Olmo, L. Gutierrez-Gonzalez, J. Samos, M. G. Picazo, M. Atienzar, and D. Garcia-Olmo Surgery and Hematogenous Dissemination: Comparison Between the Detection of Circulating Tumor Cells and of Tumor DNA in Plasma Before and After Tumor Resection in Rats Ann. Surg. Oncol., August 1, 2006; 13(8): 1136 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Allard, J. Matera, M. C. Miller, M. Repollet, M. C. Connelly, C. Rao, A. G. J. Tibbe, J. W. Uhr, and L. W. M. M. Terstappen Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases Clin. Cancer Res., October 15, 2004; 10(20): 6897 - 6904. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Kraeft, A. Ladanyi, K. Galiger, A. Herlitz, A. C. Sher, D. E. Bergsrud, G. Even, S. Brunelle, L. Harris, R. Salgia, et al. Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System Clin. Cancer Res., May 1, 2004; 10(9): 3020 - 3028. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. El-Hefnawy, S. Raja, L. Kelly, W. L. Bigbee, J. M. Kirkwood, J. D. Luketich, and T. E. Godfrey Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics Clin. Chem., March 1, 2004; 50(3): 564 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fiegl, B. Kircher, and N. Zojer Correspondence re: T. Fehm et al., Cytogenetic Evidence that Circulating Epithelial Cells in Patients with Carcinoma Are Malignant. Clin. Cancer Res., 8: 2073-2084, 2002. Clin. Cancer Res., March 1, 2003; 9(3): 1224 - 1225. [Full Text] [PDF] |
||||
![]() |
R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |